Two Sigma Advisers’s Trillium Therapeutics Inc. TRIL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-47,000
| Closed | -$825K | – | 2884 |
|
|
2021
Q3 | $825K | Sell |
47,000
-65,500
| -58% | -$1.15M | ﹤0.01% | 1708 |
|
|
2021
Q2 | $1.09M | Sell |
112,500
-78,400
| -41% | -$760K | ﹤0.01% | 1593 |
|
|
2021
Q1 | $2.05M | Sell |
190,900
-47,900
| -20% | -$514K | 0.01% | 1257 |
|
|
2020
Q4 | $3.51M | Sell |
238,800
-43,500
| -15% | -$640K | 0.01% | 974 |
|
|
2020
Q3 | $4.01M | Sell |
282,300
-63,700
| -18% | -$905K | 0.01% | 846 |
|
|
2020
Q2 | $2.8M | Buy |
346,000
+26,200
| +8% | +$212K | 0.01% | 1040 |
|
|
2020
Q1 | $1.29M | Buy |
319,800
+291,100
| +1,014% | +$1.18M | ﹤0.01% | 1344 |
|
|
2019
Q4 | $30K | Hold |
28,700
| – | – | ﹤0.01% | 2311 |
|
|
2019
Q3 | $9K | Buy |
+28,700
| New | +$9K | ﹤0.01% | 2194 |
|